{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T14:29:18Z","timestamp":1785680958929,"version":"3.56.0"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,9]]},"abstract":"<jats:p>Human papillomavirus\u2013related oropharyngeal squamous cell carcinoma (OPSCC) has favorable prognosis relative to other head and neck squamous cell carcinomas. Criteria for predicting human papillomavirus status based upon p16 staining, including difficult cases with partial staining patterns, have been developed; however, clinical validation of these criteria and the clinical significance of partial p16 staining have not been reported. Eighty-one archival OPSCC cases were initially stained for p16 by immunohistochemistry with clone G175-405. The percentage of p16<jats:sup>+<\/jats:sup> cells and percentage of confluence of p16<jats:sup>+<\/jats:sup> cells were categorized as 25%, 26% to 75%, or &gt;75%. Of all cases, 16 (20%) had partial p16 expression, with 26% to 75% p16<jats:sup>+<\/jats:sup> cells. Applying previously developed criteria of &gt;75% p16<jats:sup>+<\/jats:sup> cells or &gt;50% positive cells with &gt;25% confluence, 48 (59%) patients were categorized p16<jats:sup>+<\/jats:sup> and demonstrated expected clinical characteristics and superior disease-free survival and overall survival (<jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.001) compared with p16<jats:sup>\u2212<\/jats:sup> patients. By themselves, the partial staining patients had intermediate outcomes; however, separating the partial staining cases by degree of confluence showed that those with &gt;75% confluence had superior disease-free survival (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.042). When the 16 original partial staining cases were re-stained with the alternative anti-p16 E6H4 clone, p16 status remained concordant for all cases, but only 3 of the 16 were interpreted as demonstrating partial staining. This report shows that the prevalence of partial p16 staining varies with the antibody utilized and clinically validates the application of a graded evaluation of both the number as well as confluence of positive cells for risk stratification of patients with OPSCC.<\/jats:p>","DOI":"10.1097\/pas.0000000000000666","type":"journal-article","created":{"date-parts":[[2016,5,17]],"date-time":"2016-05-17T15:44:03Z","timestamp":1463499843000},"page":"1261-1269","source":"Crossref","is-referenced-by-count":25,"title":["Assessing p16 Status of Oropharyngeal Squamous Cell Carcinoma by Combined Assessment of the Number of Cells Stained and the Confluence of p16 Staining"],"prefix":"10.1097","volume":"40","author":[{"given":"Samuel","family":"Barasch","sequence":"first","affiliation":[{"name":"Pathology and Laboratory Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranshu","family":"Mohindra","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Hennrick","sequence":"additional","affiliation":[{"name":"Department of Pathology, Weill Cornell - New York Presbyterian Hospital, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory K.","family":"Hartig","sequence":"additional","affiliation":[{"name":"Surgery"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"Harari","sequence":"additional","affiliation":[{"name":"Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David T.","family":"Yang","sequence":"additional","affiliation":[{"name":"Pathology and Laboratory Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230922","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJMoa0912217","article-title":"Human papillomavirus and survival of patients with oropharyngeal cancer","volume":"363","author":"Ang","year":"2010","journal-title":"N Engl J Med"},{"key":"R2-20230922","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1002\/ijc.22851","article-title":"Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis","volume":"121","author":"Ragin","year":"2007","journal-title":"Int J Cancer"},{"key":"R3-20230922","doi-asserted-by":"crossref","first-page":"6758","DOI":"10.1158\/1078-0432.CCR-09-0784","article-title":"Human papillomavirus in head and neck cancer: its role in pathogenesis and clinical implications","volume":"15","author":"Chung","year":"2009","journal-title":"Clin Cancer Res"},{"key":"R4-20230922","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1093\/annonc\/mdq210","article-title":"p16 expression in oropharyngeal cancer: its impact on staging and prognosis compared with the conventional clinical staging parameters","volume":"21","author":"Fischer","year":"2010","journal-title":"Ann Oncol"},{"key":"R5-20230922","first-page":"1515","article-title":"An epidemic of oropharyngeal squamous cell carcinoma (OSCC) due to human papillomavirus (HPV) infection and aspects of treatment and prevention","volume":"31","author":"Ramqvist","year":"2011","journal-title":"Anticancer Res"},{"key":"R6-20230922","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1200\/JCO.2011.36.4596","article-title":"Human papillomavirus and rising oropharyngeal cancer incidence in the United States","volume":"29","author":"Chaturvedi","year":"2011","journal-title":"J Clin Oncol"},{"key":"R7-20230922","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1097\/PAS.0b013e3182116a45","article-title":"Isolating p16-positive\/HPV-negative oropharyngeal cancer: an effort worth making","volume":"35","author":"Perrone","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R8-20230922","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1097\/PAS.0b013e3181e84652","article-title":"p16 positive oropharyngeal squamous cell carcinoma:an entity with a favorable prognosis regardless of tumor HPV status","volume":"34","author":"Lewis","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R9-20230922","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.semradonc.2012.03.002","article-title":"Biology of human papillomavirus-related oropharyngeal cancer","volume":"22","author":"Howard","year":"2012","journal-title":"Semin Radiat Oncol"},{"key":"R10-20230922","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1038\/modpathol.2012.79","article-title":"Partial p16 staining in oropharyngeal squamous cell carcinoma: extent and pattern correlate with human papillomavirus RNA status","volume":"25","author":"Lewis","year":"2012","journal-title":"Mod Pathol"},{"key":"R11-20230922","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s12105-012-0382-3","article-title":"Equivocal p16 immunostaining in squamous cell carcinoma of the head and neck: staining patterns are suggestive of HPV status","volume":"6","author":"Chen","year":"2012","journal-title":"Head Neck Pathol"},{"key":"R12-20230922","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/01.pap.0000201828.92719.f3","article-title":"p16 expression in the female genital tract and its value in diagnosis","volume":"13","author":"O\u2019Neill","year":"2006","journal-title":"Adv Anat Pathol"},{"key":"R13-20230922","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.ijrobp.2007.05.017","article-title":"Are we influencing outcome in oropharynx cancer with intensity-modulated radiotherapy? An inter-era comparison","volume":"69","author":"Hodge","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00000478-201609000-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T22:23:32Z","timestamp":1695421412000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000478-201609000-00011"}},"subtitle":["A Validation by Clinical Outcomes"],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":13,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000000666","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]}}}